E-resources
Peer reviewed
Open access
-
Maciejewska, Magdalena; Stec, Albert; Zaremba, Michał; Maciejewski, Cezary; Rudnicka, Lidia; Sikora, Mariusz
Clinical, cosmetic and investigational dermatology, 01/2023, Volume: 16Journal Article
Systemic sclerosis is a connective tissue disease characterized by vasculopathy and progressive fibrosis, leading to multiorgan dysfunction. Given the complex and not fully elucidated pathogenesis, biomarkers of rapid disease progression and therapeutic response are lacking. Copeptin, which reflects vasopressin activity in serum, is used in diagnosing or prognosing different cardiometabolic conditions. The aim of study was to investigate the concentration of copeptin in patients with systemic sclerosis and correlate it with specific clinical symptoms. Serum copeptin was measured in patients with systemic sclerosis (34 women and 3 men; mean age 57.6 years) and in healthy individuals (n=30) using commercially available ELISA kits. According to the criteria of LeRoy our systemic sclerosis cohort consisted of 17 patients with limited cutaneous systemic sclerosis (45.9%) and 20 diffuse cutaneous systemic sclerosis patients (54.1%). According to the criteria of LeRoy our systemic sclerosis cohort consisted of 17 patients with limited cutaneous systemic sclerosis (45.9%) and 20 diffuse cutaneous systemic sclerosis patients (54.1%). The median duration of the disease was 10 4-14 years. We found significantly higher copeptin concentration in patients with systemic sclerosis (4.21 pmol/L 3.04-5.42) in comparison to control group (3.40 pmol/L 2.38-3.76, p<0.01). Copeptin significantly correlated with Raynaud's condition score (r=0.801, p<0.05). Patients with "late" capillaroscopic patterns had higher copeptin concentrations (5.37 pmol/L 4.29-8.06) than patients with "early" (2.43 pmol/L 2.25-3.20, p<0.05) and "active" patterns (3.93 pmol/L 2.92-5.16, p<0.05). Copeptin was found to be significantly higher in SSc patients with DUs (5.71 pmol/L IQR 4.85-8.06) when compared to SSc patients without DUs (3.31 pmol/L, 2.28-4.30, p<0.05). Additionally, copeptin concentration had good diagnostic accuracy in discriminating between patients with and without digital ulcers (AUC=0.863). Alprostadil decreased copeptin concentration from 4.96 4.02-6.01 to 3.86 pmol/L 3.17-4.63 (p<0.01) after 4-6 cycles of administration. Our findings suggest that copeptin may be a promising biomarker of microcirculation alterations in systemic sclerosis.
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.